Application 204724

Type
ANDA
Sponsor
GLENMARK PHARMS LTD

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001SEVELAMER HYDROCHLORIDESEVELAMER HYDROCHLORIDETABLET;ORAL400MGNoNo
002SEVELAMER HYDROCHLORIDESEVELAMER HYDROCHLORIDETABLET;ORAL800MGNoNo

NDC Listings For This Application#

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
60687-449Sevelamer HydrochlorideSevelamer HydrochlorideAmerican Health PackagingANDACurrent
60687-449Sevelamer HydrochlorideSevelamer HydrochlorideAmerican Health PackagingANDACurrent
60687-449Sevelamer HydrochlorideSevelamer HydrochlorideAmerican Health PackagingANDACurrent
68462-446sevelamer hydrochloridesevelamer hydrochlorideGlenmark Pharmaceuticals Inc., USAANDACurrent
68462-446sevelamer hydrochloridesevelamer hydrochlorideGlenmark Pharmaceuticals Inc., USAANDACurrent
68462-446sevelamer hydrochloridesevelamer hydrochlorideGlenmark Pharmaceuticals Inc., USAANDACurrent
68462-446sevelamer hydrochloridesevelamer hydrochlorideGlenmark Pharmaceuticals Inc., USAANDACurrent
68462-446sevelamer hydrochloridesevelamer hydrochlorideGlenmark Pharmaceuticals Inc., USAANDACurrent
68462-447sevelamer hydrochloridesevelamer hydrochlorideGlenmark Pharmaceuticals Inc., USAANDACurrent
68462-447sevelamer hydrochloridesevelamer hydrochlorideGlenmark Pharmaceuticals Inc., USAANDACurrent
68462-447sevelamer hydrochloridesevelamer hydrochlorideGlenmark Pharmaceuticals Inc., USAANDACurrent
68462-447sevelamer hydrochloridesevelamer hydrochlorideGlenmark Pharmaceuticals Inc., USAANDACurrent
68462-447sevelamer hydrochloridesevelamer hydrochlorideGlenmark Pharmaceuticals Inc., USAANDACurrent

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
57958ORIG2019-03-12